Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis

✍ Scribed by J.-Y. Reginster; H. W. Minne; O. H. Sorensen; M. Hooper; C. Roux; M. L. Brandi; B. Lund; D. Ethgen; S. Pack; I. Roumagnac; R. Eastell; on behalf of the Vertebral Efficacy with Risedronate Therapy (VERT) Study Group

• Publisher: Springer-Verlag
• Year: 2000
• Tongue: English
• Weight: 144 KB
• Volume: 11
• Category: Article
• ISSN: 0937-941X
• DOI: 10.1007/s001980050010